Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Sell
18,367
-110,570
-86% -$12.9M 0.18% 62
2026
Q1
$15.5M Sell
128,937
-7,750
-6% -$895K 1.26% 26
2025
Q4
$14.4M Sell
136,687
-4,050
-3% -$380K 1.18% 32
2025
Q3
$11.8M Hold
140,737
1.02% 35
2025
Q2
$11.1M Buy
140,737
+36,910
+36% +$2.93M 1.09% 30
2025
Q1
$9.32M Sell
103,827
-2,445
-2% -$228K 0.94% 35
2024
Q4
$10.6M Buy
106,272
+65,060
+158% +$6.71M 1.09% 32
2024
Q3
$4.68M Buy
41,212
+240
+0.6% +$28.5K 0.41% 50
2024
Q2
$5.07M Buy
40,972
+210
+0.5% +$27.1K 0.48% 50
2024
Q1
$5.38M Sell
40,762
-790
-2% -$97.4K 0.47% 53
2023
Q4
$4.53M Sell
41,552
-1,160
-3% -$120K 0.41% 52
2023
Q3
$4.4M Sell
42,712
-970
-2% -$105K 0.46% 52
2023
Q2
$5.04M Sell
43,682
-2,130
-5% -$242K 0.45% 54
2023
Q1
$4.87M Sell
45,812
-2,470
-5% -$267K 0.46% 54
2022
Q4
$5.36M Sell
48,282
-41,198
-46% -$4.21M 0.51% 53
2022
Q3
$7.71M Sell
89,480
-3,420
-4% -$305K 0.74% 42
2022
Q2
$8.47M Hold
92,900
0.77% 36
2022
Q1
$7.62M Hold
92,900
0.54% 46
2021
Q4
$7.12M Hold
92,900
0.5% 44
2021
Q3
$6.98M Buy
92,900
+15,640
+20% +$1.19M 0.53% 46
2021
Q2
$6.01M Buy
77,260
+15,093
+24% +$1.12M 0.37% 50
2021
Q1
$4.57M Sell
62,167
-2,578
-4% -$190K 0.28% 58
2020
Q4
$5.05M Sell
64,745
-1,813
-3% -$139K 0.33% 55
2020
Q3
$5.27M Sell
66,558
-1,897
-3% -$149K 0.36% 58
2020
Q2
$5.05M Sell
68,455
-1,499
-2% -$113K 0.34% 59
2020
Q1
$5.14M Sell
69,954
-272
-0.4% -$21.4K 0.44% 44
2019
Q4
$6.09M Sell
70,226
-43,230
-38% -$3.55M 0.26% 63
2019
Q3
$9.11M Buy
113,456
+28,578
+34% +$2.29M 0.27% 45
2019
Q2
$6.79M Buy
+84,878
New +$6.5M 0.22% 46

Other funds holding MRK

QV Investors's MRK Position: Q2 2026 in Review

QV Investors reduced its Merck (MRK) stake by 86% in Q2 2026, selling an estimated $12.9M and leaving 18,367 shares worth $2.36M. The position accounts for 0.18% of the portfolio, ranked #62.

QV Investors first reported a position in MRK in Q2 2019 and has held it in 29 quarters since. The position peaked at $15.5M in Q1 2026. 1,380 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • QV Investors held 18,367 shares of Merck worth $2.36M as of Q2 2026.
  • QV Investors sold 110,570 Merck shares in Q2 2026, an estimated $12.9M.
  • Merck made up 0.18% of QV Investors's portfolio in Q2 2026, its #62 holding.
  • QV Investors first reported a position in Merck in Q2 2019 and has held it in 29 quarters since.
  • QV Investors's Merck position peaked at $15.5M in Q1 2026.
  • 1,380 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on QV Investors's 13F filing for Q2 2026, filed 21 Jul 2026.